Cannabigerol (CBG) is a nonintoxicating phytocannabinoid gaining popularity as a self-medication for anxiety and other conditions; however, its pharmacologic…
In the Mix: 7 More Articles — March 16, 2026
In the Mix — Last 24 HoursMarch 16, 2026. 7 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25LEGACY CANNABIS BRAND ANNOUNCES NATIONWIDE PRODUCT...
CED Digest: 436 Items — March 14, 2026
CED DigestMarch 14, 2026. 436 items curated for clinical relevance. Above Threshold #97Alabama Medical Cannabis Sales Gear for Spring 2026 Launch# Summary Alabama's medical cannabis program is preparing to begin patient sales...
Cannabis Compounds CBD and CBG Show Promise in Fighting Fatty Liver Disease
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDHempSafety Why This Matters Clinicians managing patients with non-alcoholic fatty liver disease now have emerging...
CBD and CBG promising treatments for fatty liver disease, a new study finds – leafie
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDHemp Why This Matters Clinicians managing patients with metabolic dysfunction-associated fatty liver disease currently lack...
Scientists Discover How Cannabis Compounds May Fight Fatty Liver Disease – NDTV
✦ New CED Clinical Relevance#72Notable Clinical InterestEmerging findings or policy developments worth monitoring closely. ResearchCBDHemp Why This MattersClinicians managing patients with nonalcoholic fatty liver disease now have preliminary evidence that CBD and...